Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1602-1609
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Groups | Dose (μg/mL) | Migration | Invasion | ||
Cell number | Inhibition rate (%) | Cell number | Inhibition rate (%) | ||
Control | 0.0 | 69.40 ± 6.38 | 0.00 ± 0.00 | 65.60 ± 7.20 | 0.00 ± 0.00 |
Toxicarioside A | 0.5 | 62.50 ± 8.90 | 10.01 ± 9.78 | 57.80 ± 4.32 | 10.89 ± 8.64 |
1.5 | 54.80 ± 7.30 | 22.38 ± 10.64a | 49.70 ± 5.68 | 24.03 ± 9.06a | |
4.5 | 41.60 ± 5.88 | 39.58 ± 11.62a | 36.40 ± 7.94 | 44.68 ± 9.19a | |
9.0 | 35.80 ± 8.32 | 48.13 ± 10.12b | 30.10 ± 6.46 | 54.38 ± 8.17b |
-
Citation: Guo JL, Zheng SJ, Li YN, Jie W, Hao XB, Li TF, Xia LP, Mei WL, Huang FY, Kong YQ, He QY, Yang K, Tan GH, Dai HF. Toxicarioside A inhibits SGC-7901 proliferation, migration and invasion
via NF-κB/bFGF signaling. World J Gastroenterol 2012; 18(14): 1602-1609 - URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1602.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i14.1602